Viking Therapeutics, Inc. (VKTX) cash on hand

Cash · fiscal 2025
$705.74M

Viking Therapeutics, Inc. (VKTX) held cash of $705.74M at the end of fiscal 2025 (December 31, 2025). That is 21.8% lower than the $902.61M of fiscal 2024. Figures as of 18 Nov 2026, 10:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$705.74M
Change on fiscal 2024
−21.8%
Highest on record
$902.61Mfiscal 2024
Lowest on record
$155.49Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Viking Therapeutics, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $902.61M in fiscal 2024 and the lowest $155.49M in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Viking Therapeutics, Inc. cash on hand, year by year

Viking Therapeutics, Inc. (VKTX) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$705.74M 21.8% down
2024$902.61M 149.3% up
2023$362.08M 132.9% up
2022$155.49M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on VKTX

Viking Therapeutics, Inc., figure by figure

Viking Therapeutics, Inc. (VKTX) overview: price, valuation and scorecard

Viking Therapeutics, Inc. cash on hand: questions and answers

How much cash does Viking Therapeutics, Inc. have?

Viking Therapeutics, Inc. (VKTX) held cash of $705.74M at the end of fiscal 2025 (December 31, 2025). That is 21.8% lower than the $902.61M of fiscal 2024.

What are the highest and lowest cash figures on record for Viking Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $902.61M in fiscal 2024 and the lowest $155.49M in fiscal 2022.

How is Viking Therapeutics, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Viking Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Viking Therapeutics, Inc. (VKTX) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/VKTX/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.